Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905073 · ClinicalTrials.gov registry record · NA
Low Dose Cyclosporin and Methotrexate Therapy in Diabetes
A NA study of Type 1 Diabetes Mellitus, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT00905073: Completed NA study of Type 1 Diabetes Mellitus, sponsored by Georgetown University.
NCT00905073 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Georgetown University. The registered enrollment target is 8 participants, below the 172-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00905073, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether treatment with low dose cyclosporin and methotrexate can inhibit the development of new onset diabetes mellitus
Conditions Studied
Interventions
- DRUG cyclosporin and methotrexate
Study Locations (1)
District of Columbia
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 1990-02 |
| Est. Completion | 1994-06 |
| Phase | NA |
What the finished NCT00905073 record still lists
NCT00905073 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 172-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which cyclosporin and methotrexate is the first listed.
NCT00905073 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00905073 about?
NCT00905073 is a clinical study titled "Low Dose Cyclosporin and Methotrexate Therapy in Diabetes". The purpose of this study is to determine whether treatment with low dose cyclosporin and methotrexate can inhibit the development of new onset diabetes mellitus
What is the current status of trial NCT00905073?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 1990-02. Estimated completion is 1994-06.
What conditions does trial NCT00905073 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT00905073?
The interventions under investigation include: cyclosporin and methotrexate (DRUG).
Who is sponsoring clinical trial NCT00905073?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00905073 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00905073's enrollment target sits among peer trials
8 112th of 112 higher than 1 of 112 other Type 1 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia